Vasospasmolytic therapy in patients with SSC.
Jünger
M
M
Department of Dermatology, University Hospital of Tübingen, Germany.
Schlez
A
A
Klyscz
T
T
Steins
A
A
Hahn
M
M
D000527:Alprostadil / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D003080:Cold Temperature; D006801:Humans; D016285:Iloprost / Q000627:therapeutic use; D008833:Microcirculation / Q000187:drug effects; D020678:Microscopic Angioscopy; D017063:Outcome Assessment, Health Care; D011928:Raynaud Disease / Q000188:drug therapy* / Q000209:etiology; D012039:Regional Blood Flow / Q000187:drug effects; D012595:Scleroderma, Systemic / Q000150:complications / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000806:Angiotensin-Converting Enzyme Inhibitors; D014665:Vasodilator Agents; D000527:Alprostadil; D016285:Iloprost